摘要
背景:类风湿性关节炎(RA)和骨关节炎(OA)是以持续性炎症和关节破坏为特征的广泛风湿性疾病。硫化氢(H2S)是一种在脑,脉管系统和其他器官中具有重要生理功能的内源性气体。最近的研究发现,H2S是炎症性关节疾病的介质。 目的:本综述总结了近期该领域的文献,突出了相关的发展。 结论:几位作者发现,H2S在急性关节炎的啮齿动物模型和RA和OA组织使用人滑膜细胞和关节软骨细胞的体外模型中显示出抗炎,抗分解代谢和/或抗氧化作用。最早的研究使用了快速溶解盐,如NaSH,但GYY4137在生理上产生的硫化氢不久就出现了。最近,还合成了靶向线粒体的新的形成H 2 S的化合物。这些化合物开启了研究H2S在细胞生物能量学中的作用的兴奋机会,通常在关节炎中被改变。当H2S作为硫酸水浴施用时,也获得了积极的结果,值得进一步研究。这些发现表明,外源性补充H2S可能为这些疾病提供可行的治疗选择,特别是OA。
关键词: 炎性关节病,类风湿关节炎,骨关节炎,硫化氢,线粒体,亚硫酸泉水。
Current Drug Targets
Title:Hydrogen Sulfide and Inflammatory Joint Diseases
Volume: 18 Issue: 14
关键词: 炎性关节病,类风湿关节炎,骨关节炎,硫化氢,线粒体,亚硫酸泉水。
摘要: Background: Rheumatoid arthritis (RA) and osteoarthritis (OA) are widespread rheumatic diseases characterized by persistent inflammation and joint destruction. Hydrogen sulfide (H2S) is an endogenous gas with important physiologic functions in the brain, vasculature and other organs. Recent studies have found H2S to be a mediator in inflammatory joint diseases.
Objective: This review summarizes the recent literature in this area highlighting relevant developments.
Conclusions: Several authors have found that H2S exhibited anti-inflammatory, anti-catabolic and/or anti-oxidant effects in rodent models of acute arthritis and in in vitro models using human synoviocytes and articular chondrocytes from RA and OA tissues. The earliest studies used fast-dissolving salts, such as NaSH, but GYY4137, which produces H2S more physiologically, shortly appeared. More recently still, new H2S-forming compounds that target mitochondria have been synthesized. These compounds open exciting opportunities for investigating the role of H2S in cell bioenergetics, typically altered in arthritides. Positive results have also been obtained when H2S is administered as a sulphurous water bath, an option meriting further study. These findings suggest that exogenous supplementation of H2S may provide a viable therapeutic option for these diseases, particularly in OA.
Export Options
About this article
Cite this article as:
Hydrogen Sulfide and Inflammatory Joint Diseases, Current Drug Targets 2017; 18 (14) . https://dx.doi.org/10.2174/1389450117666160829112824
DOI https://dx.doi.org/10.2174/1389450117666160829112824 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response and/or therapy ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potent Inhibitory Effects of Quercetin on Inflammatory Responses of Collagen-Induced Arthritis in Mice
Endocrine, Metabolic & Immune Disorders - Drug Targets The ERK and p38MAPK Pathways as Targets for Anti-Inflammatory Therapy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Stress Hormone-Mediated DNA Damage Response -- Implications for Cellular Senescence and Tumour Progression
Current Drug Targets Design, Synthesis and Characterization of N', N'-Diaryl Ureas as p38 Kinase Inhibitors
Medicinal Chemistry Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Focus on Virus Induced Exacerbations
Current Pharmaceutical Design Adjunctive Immunotherapy of Mycobacterial Infections
Current Pharmaceutical Design Recent Progress in Therapeutic and Diagnostic Applications of Lanthanides
Mini-Reviews in Medicinal Chemistry Venous Thromboembolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in the Arabian Gulf
Current Vascular Pharmacology Predicting Toxicity: Biomarkers and the Value of the Patient's Opinion
Current Pharmaceutical Design Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases
Current Pharmaceutical Design Pharmacogenomic Approaches to Osteoporosis: 2005 Update
Current Pharmacogenomics Regulation of Adaptive Immunity by the Neurotransmitter Norepinephrine
Current Immunology Reviews (Discontinued) Meet the Editorial Board Member
Current Drug Targets Natural and Synthetic Inhibitors of Caspases: Targets for Novel Drugs
Current Drug Targets - CNS & Neurological Disorders Osteoblasts and Osteoclasts in Bone Remodeling and Inflammation
Current Drug Targets - Inflammation & Allergy IL-6 and Crohns Disease
Current Drug Targets - Inflammation & Allergy The Clinical Potential of Worms and their Products in Treating Inflammatory Diseases
Current Immunology Reviews (Discontinued) Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design Animal Models of Lupus and Lupus Nephritis
Current Pharmaceutical Design Meet Our Editorial Board Member:
Current Drug Discovery Technologies